Clinical Trial: Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: A Post Marketing, Multi-Center, Trial to Measure Human Anti-Human Antibodies (HAHA) to Soliris (Eculizumab) in Patients With Paroxysmal Nocturnal Hemoglobinuria

Brief Summary: How does long term treatment with Soliris affect HAHA in PNH patients?